Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
about
Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Capecitabine and cisplatin (XP ...... tive metastatic breast cancer.
@ast
Capecitabine and cisplatin (XP ...... tive metastatic breast cancer.
@en
type
label
Capecitabine and cisplatin (XP ...... tive metastatic breast cancer.
@ast
Capecitabine and cisplatin (XP ...... tive metastatic breast cancer.
@en
prefLabel
Capecitabine and cisplatin (XP ...... tive metastatic breast cancer.
@ast
Capecitabine and cisplatin (XP ...... tive metastatic breast cancer.
@en
P2093
P2860
P1433
P1476
Capecitabine and cisplatin (XP ...... tive metastatic breast cancer.
@en
P2093
Hyun Ho Kim
Ji Hyun Yang
Sang Mi Ro
P2860
P304
P356
10.1371/JOURNAL.PONE.0171605
P407
P577
2017-02-24T00:00:00Z